PMID: 16501733Feb 28, 2006Paper

Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage

Bulletin of the World Health Organization
J Ties BoermaPeter D Ghys

Abstract

This paper reviews the data sources and methods used to estimate the number of people on, and coverage of, antiretroviral therapy (ART) programmes in low- and middle-income countries and to monitor the progress towards the "3 by 5" target set by WHO and UNAIDS. We include a review of the data sources used to estimate the coverage of ART programmes as well as the efforts made to avoid double counting and over-reporting. The methods used to estimate the number of people in need of ART are described and expanded with estimates of treatment needs for children, both for ART and for cotrimoxazole prophylaxis. An estimated 6.5 million people were in need of treatment in low- and middle-income countries by the end of 2004, including 660,000 children under age 15 years. The mid-2005 estimate of 970,000 people receiving ART in low- and middle-income countries (with an uncertainty range 840,000-1,100,000) corresponds to a coverage of 15% of people in need of treatment.

Citations

Jan 16, 2007·Epidemiology and Infection·R G WhiteP E M Fine
Jul 2, 2008·PLoS Medicine·Timothy B HallettUNKNOWN ALPHA Network
Oct 20, 2007·AIDS Patient Care and STDs·Till BärnighausenSalal Humair
Nov 27, 2008·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Patricia A PatrickJesus Aguais
Oct 11, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David W LowranceKelita Kamoto
Nov 26, 2014·AIDS Research and Human Retroviruses·Mingli LiBaiqing Dong
Aug 6, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine G SutcliffeWilliam J Moss
Jul 21, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·David W LowranceAnita Assimwe
Jan 5, 2010·Current Opinion in HIV and AIDS·Mary MahyYves Souteyrand
Apr 10, 2009·Journal of the International Association of Physicians in AIDS Care : JIAPAC·G M IkomeyP M Ndumbe
Jun 4, 2008·Scandinavian Journal of Public Health·Annemarie R BollerupSrdan Matic
Dec 4, 2012·Journal of the International AIDS Society·Kimon DivarisGodfrey Woelk
Jul 11, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Arthi VijayaraghavanChristopher C Santas
Sep 28, 2007·The Lancet Infectious Diseases·Rony ZachariahStephen M Graham

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.